Reply to YiJun Shen and DingWei Ye's letter to the Editor re: Gregory R. Pond, Andrew J. Armstrong, Brian A. Wood, et al. Evaluating the value of number of cycles of docetaxel and prednisone in men with metastatic castration-resistant prostate cancer. Eur Urol 2012;61:363-9
Publication
, Journal Article
Sonpavde, G; Pond, GR; Armstrong, AJ
Published in: European Urology
February 1, 2012
Duke Scholars
Published In
European Urology
DOI
EISSN
1873-7560
ISSN
0302-2838
Publication Date
February 1, 2012
Volume
61
Issue
2
Related Subject Headings
- Urology & Nephrology
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Sonpavde, G., Pond, G. R., & Armstrong, A. J. (2012). Reply to YiJun Shen and DingWei Ye's letter to the Editor re: Gregory R. Pond, Andrew J. Armstrong, Brian A. Wood, et al. Evaluating the value of number of cycles of docetaxel and prednisone in men with metastatic castration-resistant prostate cancer. Eur Urol 2012;61:363-9. European Urology, 61(2). https://doi.org/10.1016/j.eururo.2011.07.055
Sonpavde, G., G. R. Pond, and A. J. Armstrong. “Reply to YiJun Shen and DingWei Ye's letter to the Editor re: Gregory R. Pond, Andrew J. Armstrong, Brian A. Wood, et al. Evaluating the value of number of cycles of docetaxel and prednisone in men with metastatic castration-resistant prostate cancer. Eur Urol 2012;61:363-9.” European Urology 61, no. 2 (February 1, 2012). https://doi.org/10.1016/j.eururo.2011.07.055.
Sonpavde G, Pond GR, Armstrong AJ. Reply to YiJun Shen and DingWei Ye's letter to the Editor re: Gregory R. Pond, Andrew J. Armstrong, Brian A. Wood, et al. Evaluating the value of number of cycles of docetaxel and prednisone in men with metastatic castration-resistant prostate cancer. Eur Urol 2012;61:363-9. European Urology. 2012 Feb 1;61(2).
Sonpavde, G., et al. “Reply to YiJun Shen and DingWei Ye's letter to the Editor re: Gregory R. Pond, Andrew J. Armstrong, Brian A. Wood, et al. Evaluating the value of number of cycles of docetaxel and prednisone in men with metastatic castration-resistant prostate cancer. Eur Urol 2012;61:363-9.” European Urology, vol. 61, no. 2, Feb. 2012. Scopus, doi:10.1016/j.eururo.2011.07.055.
Sonpavde G, Pond GR, Armstrong AJ. Reply to YiJun Shen and DingWei Ye's letter to the Editor re: Gregory R. Pond, Andrew J. Armstrong, Brian A. Wood, et al. Evaluating the value of number of cycles of docetaxel and prednisone in men with metastatic castration-resistant prostate cancer. Eur Urol 2012;61:363-9. European Urology. 2012 Feb 1;61(2).
Published In
European Urology
DOI
EISSN
1873-7560
ISSN
0302-2838
Publication Date
February 1, 2012
Volume
61
Issue
2
Related Subject Headings
- Urology & Nephrology
- 3202 Clinical sciences
- 1103 Clinical Sciences